Phreesia, Inc. PHR
NYSE · United States · Technology Services
$10.36+0.03 (+0.29%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
ALL-REMOTE COMPANY/WILMINGTON, Del., September 30, 2026--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME’s list of the World’s Top HealthTech Companies of 2026. This marks the second consecutive year Phreesia has been recognized on the list, which is developed in partnership with Statista to identify companies using technology to make healthcare more effective and accessible.
On September 2, 2026, Phreesia, Inc. (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, 2026. Revenue rose 10% to $129.5 million and adjusted EBITDA climbed to $32.9 million from $22.1 million a year earlier, a 25% margin. Net income reached $1.9 million, marking the company’s fifth consecutive quarter of profitability. Management […]
ALL-REMOTE COMPANY/WILMINGTON, Del., September 14, 2026--Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace.
On September 2, Phreesia (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, showing revenue climbing to $129.5 million and adjusted EBITDA surging to $32.9 million. The healthcare technology company posted its fifth straight quarter of positive net income and its ninth straight quarter of positive operating cash flow, even as management […]
Moby summary of Phreesia, Inc.'s Q2 2027 earnings call
Phreesia Inc (PHR) delivers 10% revenue growth and 25% adjusted EBITDA margin while expanding AccessOne and AI-driven Network Solutions.
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ALL-REMOTE COMPANY/WILMINGTON, Del., September 02, 2026--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026.
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +42.11% and -4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.
Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.